Clinical Trial Update: Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rezafungin versus standard antimicrobial prophylaxis to prevent invasive fungal diseases in adults undergoing allogeneic hematopoietic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidemia
• Invasive Candidiasis
• Invasive Fungal Infection
• Invasive Mold Infection
• Pneumocystis Pneumonia

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Candidemia, Mycoses | Phase 3 | Status: COMPLETED